Acorda Therapeutics
Troy Bartron Jr. is an experienced formulation scientist with a robust background in pharmaceutical development and project management. Currently serving as Scientist I - Formulation Development at Acorda Therapeutics, Inc., since July 2022, Troy previously held positions as Senior Formulation Scientist at Pace® Life Sciences and Formulation Scientist at Emerson Resources Inc., where expertise in GMP compliance and clinical trial support was demonstrated. Troy's experience encompasses a wide range of formulation processes, including the development of small molecule dosage forms, management of GMP operations, and the coordination of in-house and client-facing projects. Prior roles included Associate Research Scientist at Specialty Assays Inc., focusing on organic synthesis and enzymatic substrate development, complemented by early experience as a Pharmacy Technician at Wegmans Food Markets. Troy holds a Bachelor of Science in Biochemistry from Moravian University.
This person is not in any offices
Acorda Therapeutics
1 followers
Acorda Therapeutics is a publicly-traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders.